These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17339335)

  • 41. ETS1 targets RYBP transcription to inhibit tumor cell proliferation.
    Zhao W; Zhang S; Wang X; Ma X; Huang B; Chen H; Chen D
    Biochem Biophys Res Commun; 2019 Feb; 509(3):810-816. PubMed ID: 30638661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The biology of the Ets1 proto-oncogene.
    Dittmer J
    Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ets-1 p51 and p42 isoforms differentially modulate Stromelysin-1 promoter according to induced DNA bend orientation.
    Leprivier G; Baillat D; Begue A; Hartmann B; Aumercier M
    Nucleic Acids Res; 2009 Jul; 37(13):4341-52. PubMed ID: 19465391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.
    Zhan Y; Brown C; Maynard E; Anshelevich A; Ni W; Ho IC; Oettgen P
    J Clin Invest; 2005 Sep; 115(9):2508-16. PubMed ID: 16138193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements.
    Gabrielli S; Sun M; Bell A; Zook EC; de Pooter RF; Zamai L; Kee BL
    Eur J Immunol; 2017 May; 47(5):800-805. PubMed ID: 28276053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation.
    Conte D; Liston P; Wong JW; Wright KE; Korneluk RG
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5049-54. PubMed ID: 11309492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
    Ghazi-Visser L; Laman JD; Nagel S; van Meurs M; van Riel D; Tzankov A; Frank S; Adams H; Wolk K; Terracciano L; Melief MJ; Sabat R; Günthert U
    FASEB J; 2013 Sep; 27(9):3683-701. PubMed ID: 23752202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-cell analysis of Ets-1 transcription factor expression during lymphocyte activation and apoptosis.
    Koskela K; Lassila O
    Scand J Immunol; 2003 Jan; 57(1):56-61. PubMed ID: 12542798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.
    Kabbout M; Dakhlallah D; Sharma S; Bronisz A; Srinivasan R; Piper M; Marsh CB; Ostrowski MC
    PLoS One; 2014; 9(6):e100693. PubMed ID: 24968297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The transcription factor ETS1 in lymphomas: friend or foe?
    Testoni M; Chung EY; Priebe V; Bertoni F
    Leuk Lymphoma; 2015 Jul; 56(7):1975-80. PubMed ID: 25363344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial Loss of ETS1 Impairs Coronary Vascular Development and Leads to Ventricular Non-Compaction.
    Wang L; Lin L; Qi H; Chen J; Grossfeld P
    Circ Res; 2022 Aug; 131(5):371-387. PubMed ID: 35894043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gata3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis.
    Liu S; Chan HL; Bai F; Ma J; Scott A; Robbins DJ; Capobianco AJ; Zhu P; Pei XH
    Oncotarget; 2016 Sep; 7(39):64007-64020. PubMed ID: 27588406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ETS1 Function in Leukemia and Lymphoma.
    Luchtel RA
    Adv Exp Med Biol; 2024; 1459():359-378. PubMed ID: 39017852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells.
    Nagarajan P; Parikh N; Garrett-Sinha LA; Sinha S
    PLoS One; 2009; 4(1):e4179. PubMed ID: 19142229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.
    Wei G; Srinivasan R; Cantemir-Stone CZ; Sharma SM; Santhanam R; Weinstein M; Muthusamy N; Man AK; Oshima RG; Leone G; Ostrowski MC
    Blood; 2009 Jul; 114(5):1123-30. PubMed ID: 19411629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment.
    Schenk RL; Tuzlak S; Carrington EM; Zhan Y; Heinzel S; Teh CE; Gray DH; Tai L; Lew AM; Villunger A; Strasser A; Herold MJ
    Cell Death Differ; 2017 Mar; 24(3):534-545. PubMed ID: 28085150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis of Ets1 cooperative binding to palindromic sequences on stromelysin-1 promoter DNA.
    Babayeva ND; Wilder PJ; Shiina M; Mino K; Desler M; Ogata K; Rizzino A; Tahirov TH
    Cell Cycle; 2010 Aug; 9(15):3054-62. PubMed ID: 20686355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of Ets1 structure, function, and roles in immunity.
    Garrett-Sinha LA
    Cell Mol Life Sci; 2013 Sep; 70(18):3375-90. PubMed ID: 23288305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Morphological and functional peculiarities of lymphoid cells in mice of different strains.
    Gol'dberg ED; Masnaya NV; Churin AA
    Bull Exp Biol Med; 2004 Jun; 137(6):622-4. PubMed ID: 15455101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p89c-Myb is not required for fetal or adult hematopoiesis.
    Baker SJ; Kumar A; Reddy EP
    Genesis; 2010 May; 48(5):309-16. PubMed ID: 20196078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.